With trial costs rising over the past decade and concerns they’ll keep climbing, companies are seeking ways to manage ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...

Somerville, Mass-based Mass General Brigham has rolled out ambient documentation using generative AI to help draft clinical ...

Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...

A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic pontine glioma (DIPG) is safe, reported Weill Cornell Medicine and ...

“We will provide additional safety, pharmacokinetic (PK) and pharmacodynamic (PD) data over the next several weeks.” The ongoing Phase 1 clinical trial is a multi-center, open-label, dose ...

Candel Therapeutics (CADL) announced the publication of a manuscript reporting the results of a phase 1b clinical trial exploring safety and ...